Skip to main content
. 2003 Nov;133(3):978–988. doi: 10.1104/pp.103.029223

Figure 1.

Figure 1.

A and B, Western-blot detection. A, VirE2 antibodies: 1, LBA1100; 2, LBA2571; 3, LBA1100(Cre::VirE2); 4, LBA2571 (Cre::VirE2); 5, LBA1100(Cre::VirE2-50C); 6, LBA2571(Cre:: VirE2-50C); 7, LBA1100(Cre::VirE3-50C); 8, LBA2571(Cre:: VirE3-50C); 9, virD4(Cre::VirE2-50C). B, Cre antibodies: 1, LBA1100(Cre::VirE2-50C); 2, LBA2571(Cre::VirE2-50C); 3, LBA1100(Cre::VirE3-50C); 4, LBA2571(Cre::VirE3-50C); 5, virD4 (Cre::VirE2-50C). M, Molecular weight marker (kD). C, Tumor assay on N. glauca with LBA1010 and LBA2570 (virE1). Triangles in a, Cre::VirE2; in b, VirE2; in c, Cre::VirE2_50C.